Table 4.
100 mg of DYM | 100 mg of DYM + 50 mg of TCR | 150 mg of DYM + 25 mg of TCR | 150 mg of DYM | Placebo | Average | ||
---|---|---|---|---|---|---|---|
Absolute Neutrophils (× 103/µL) |
Visit 2 | 2.68 ± 1.04 | 3.06 ± 1.47 | 2.82 ± 0.85 | 2.77 ± 1.24 | 2.56 ± 1.30 | 2.77 ± 1.18 |
Visit 3 | 2.78 ± 1.28 | 2.85 ± 1.58 | 2.82 ± 0.85 | 2.58 ± 1.12 | 2.60 ± 0.90 | 2.72 ± 1.15 | |
Absolute Lymphocytes (× 103/µL) |
Visit 2 | 2.09 ± 0.33 | 2.31 ± 0.44 | 2.30 ± 0.50 | 2.13 ± 0.51 | 2.07 ± 0.51 | 2.18 ± 0.47 |
Visit 3 | 2.25 ± 0.50 | 2.31 ± 0.72 | 2.24 ± 0.51 | 2.20 ± 0.48 | 2.20 ± 0.60 | 2.24 ± 0.56 | |
Absolute Monocytes (× 103/µL) |
Visit 2 | 0.463 ± 0.124 | 0.519 ± 0.172 | 0.432 ± 0.149 | 0.396 ± 0.112 | 0.475 ± 0.165 | 0.455 ± 0.149 |
Visit 3 | 0.445 ± 0.122 | 0.491 ± 0.216 | 0.470 ± 0.122 | 0.414 ± 0.159 | 0.467 ± 0.134 | 0.458 ± 0.153 | |
Absolute Eosinophils (× 103/µL) |
Visit 2 | 0.183 ± 0.169 | 0.162 ± 0.102 | 0.144 ± 0.112 | 0.138 ± 0.077 | 0.175 ± 0.099 | 0.160 ± 0.116 |
Visit 3 | 0.186 ± 0.146 | 0.191 ± 0.177 | 0.157 ± 0.112 | 0.181 ± 0.112 | 0.192 ± 0.132 | 0.181 ± 0.136 * | |
Absolute Basophils (× 103/µL) |
Visit 2 | 0.017 ± 0.038 | 0.014 ± 0.036 | 0.012 ± 0.033 | <0.010 | <0.010 | 0.008 ± 0.028 |
Visit 3 | 0.009 ± 0.029 | 0.009 ± 0.029 | 0.027 ± 0.046 | 0.014 ± 0.036 | 0.008 ± 0.028 | 0.014 ± 0.034 | |
Immature Granulocytes (× 103/µL) |
Visit 2 | 0.208 ± 0.415 | 0.429 ± 0.978 | 0.080 ± 0.277 | 0.261 ± 0.689 | 0.333 ± 0.637 | 0.256 ± 0.632 |
Visit 3 | 0.318 ± 0.477 | 0.364 ± 0.79 | <0.010 | 0.048 ± 0.218 | 0.208 ± 0.658 | 0.188 ± 0.529 | |
Absolute Immature Granulocytes (× 103/µL) |
Visit 2 | 0.017 ± 0.038 | 0.029 ± 0.072 | 0.004 ± 0.020 | 0.009 ± 0.029 | 0.025 ± 0.044 | 0.016 ± 0.043 |
Visit 3 | 0.014 ± 0.035 | 0.014 ± 0.035 | <0.010 | 0.010 ± 0.030 | 0.013 ± 0.034 | 0.010 ± 0.030 |
* Significantly (p < 0.05) different from Visit 2.